This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Drug Therapy, Other  • Transplantation, Other  • Dermatologic Disorders, Other  • Phototherapy  • Drug Therapy  • Alert me on articles by topic

To Treat or Not to Treat

Henry W. Lim, MD; Camile L. Hexsel, MD

Arch Dermatol. 2007;143(5):643-646.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Treatment of vitiligo involves either repigmentation or depigmentation, depending on the extent of the disease. Additional adjuvant forms of management include cosmetic cover-up and psychological and social support. Support groups can be located through the National Vitiligo Foundation (http://www.nvfi.org). Topical dihydroxyacetone-containing self-tanning preparations, topical dyes, and tattooing have also been used¹ but generally do not result in ideal color match with the unaffected skin.

Based on a review of published studies, a suggested treatment algorithm is shown in the Figure. In this editorial, we review published studies of the management of vitiligo, focusing primarily on the more recent studies with a high level of evidence (Table). Level of evidence was graded on a 5-point scale as follows¹⁷: (I) at least 1 properly designed randomized controlled trial; (II-1) well-designed controlled trial without randomization; (II-2) well-designed cohort or . . . [Full Text of this Article]

REPIGMENTATION PHOTOTHERAPY AND PHOTOCHEMOTHERAPY


TARGETED PHOTOTHERAPY

TOPICAL, INTRALESIONAL, AND SYSTEMIC CORTICOSTEROID AGENTS

TOPICAL CALCINEURIN INHIBITORS

TOPICAL CALCIPOTRIENE

SURGICAL REPIGMENTATION

DEPIGMENTATION

SUMMARY

AUTHOR INFORMATION

RELATED ARTICLE

Randomized Double-blind Trial of Treatment of Vitiligo: Efficacy of Psoralen–UV-A Therapy vs Narrowband–UV-B Therapy
Sami Sasi Yones, Roy A. Palmer, Trish M. Garibaldinos, and John L. M. Hawk
Arch Dermatol. 2007;143(5):578-584.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Repigmentation in Vitiligo: PUVA vs. Narrowband UVB
Journal Watch Dermatology 2007;2007:1-1.
FULL TEXT